中国与美国非处方药管理体系的对比研究  

Contrastive study of non-prescription drug management systems in China and United States

作　　者：胡骏 颜建周[1] 邵蓉[1] HU Jun;YAN Jian-zhou;SHAO Bong(China Pharmaceutical University, Nanjing 211198 , China)

机构地区：[1]中国药科大学,南京211198

出　　处：《中国新药杂志》2019年第6期641-645,共5页Chinese Journal of New Drugs

基　　金：中国创新药物政策环境研究资助项目(15ZDB167)

摘　　要：本文从非处方药的准入模式、经营管理、广告管理、执业药师管理、医保政策5个方面进行美国与中国非处方药管理体系的现状分析,通过对比研究为完善我国非处方药相关制度提供政策建议。By analyzing the status quo of non-prescription drug management systems in China and United States from five aspects, i. e., access mode , operation management, advertising management, licensed pharmacist management and health insurance policy , suggestions were provided to perfect the system of non-prescription drugs in China.

关 键 词：非处方药 管理体系 药品分类管理制度 

分 类 号：R95[医药卫生—药学]